-+ 0.00%
-+ 0.00%
-+ 0.00%

MannKind to Present New Inhaled Insulin Data at Global Diabetes Conference in Amsterdam

Benzinga·03/10/2025 10:08:14
Listen to the news

MannKind Corporation (NASDAQ:MNKD), a company focused on the development and commercialization of inhaled therapeutic products and delivery devices for patients with endocrine and orphan lung diseases, will showcase data from recent studies of inhaled insulin across five presentations at the 18th International Conference on Advanced Technologies and Treatments for Diabetes to be held March 19-22 in Amsterdam.